Sponsor Pipeline

Jie Chang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06945666 A Study of Iguratimod in Combination With Tofacitinib in RA Patients Rheumatoid Arthritis (RA Not Yet Recruiting
Disease Areas
Rheumatoid Arthritis (1)
Get alerts when Jie Chang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free